Common Warts | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

11,761 results for “Common Warts”

Verrica Pharmaceuticals Initiates Phase 3 Trial for VP-102 in Common Warts Treatment

Nielsen BioSciences' CANDIN Achieves Primary Endpoint in First Phase 3 Trial for Common Warts Treatment

Verrica Doses First U.S. and Japanese Patients in Phase 3 COVE-3 Trial of YCANTH for Common Warts

Verrica Pharmaceuticals Launches Global Phase 3 Trial for YCANTH in Common Warts, Targeting 22 Million US Patients

Nielsen BioSciences Completes Phase 3 Enrollment for Novel Wart Treatment CANDIN

Verrica Pharmaceuticals Secures $50 Million Financing to Advance Dermatology Pipeline and Eliminate Debt

Torii Pharmaceutical Submits NDA in Japan for Verrica's Molluscum Contagiosum Treatment, TO-208

Verrica Pharmaceuticals Receives EMA Support for YCANTH European Approval Without Additional Phase 3 Studies

Verrica to Present VP-315 Immune Activation Data from Phase 2 Basal Cell Carcinoma Trial at SITC 2025

Verrica Pharmaceuticals Reports Record Growth in YCANTH® Dispensed Units for Molluscum Contagiosum Treatment

Page 1 of 742